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Cardiovascular diseaseOur ability to understand the pathogenesis of problems surrounding lipid accretion requires attention towards
quantifying lipid kinetics. In addition, studies of metabolic ﬂux should also help unravel mechanisms that lead
to imbalances in inter-organ lipid trafﬁcking which contribute to dyslipidemia and/or peripheral lipid accumu-
lation (e.g. hepatic fat deposits). This review aims to outline the development and use of novel methods for
studying lipid kinetics in vivo. Although our focus is directed towards some of the approaches that are currently
reported in the literature, we include a discussion of the older literature in order to put “new”methods in better
perspective and inform readers of valuable historical research. Presumably, future advances in understanding
lipid dynamics will beneﬁt from a careful consideration of the past efforts, where possible we have tried to iden-
tify seminal papers or those that provide clear data to emphasize essential points. This article is part of a Special
Issue entitled: Modulation of Adipose Tissue in Health and Disease.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Adipose tissue is broadly divided into two major categories, white
adipose provides insulation, cushions vital organs and acts as an endo-
crine organ whereas brown adipose tissue is generally thought to con-
tribute to thermogenesis. As small molecules, lipids are an excellent
fuel source, in addition, they play a critical role in subcellular signal trans-
duction. The accumulation of lipids (or adipose tissue) during growth is
comparable to the accumulation of lean bodymass, for example, a 3.5 kg
newborn babywill accumulate ~12 kg of fat vs ~12 kg of (dry) leanmass
as they transition to a healthy 75 kg adult, reminding us that “getting fat”
is part of being normal (obviously, toomuch of a good thing is bad). Note
that a majority of weight gain is simply water mass, a relatively small
amount of fat-free lean mass reﬂects true nitrogen accretion whereas
fat mass has very little hydration making the accumulation of lipid and
muscle comparable.
The aim of this review is to outline methods that are available for
quantifying lipid ﬂux, although attention will be directed towards new
advances we intend to highlight selected examples from the older liter-
ature since this may help to identify gaps for future investigations. The
perspective used in discussing these methods is based on our experi-
ence studying the biochemical basis of triglyceride accumulation inion of Adipose Tissue in Health
vis).
l rights reserved.adipose tissue and the role of adipose dysfunction in the pathogenesis
of dyslipidemia and cardiometabolic disorders, comparable methods
can be used for both purposes.
Although numerous investigators have studied de novo lipogenesis
[3,38,65,155], most experiments do not allow conclusions regarding
net lipid balance. We had suspected that in order to develop a compre-
hensive understanding of lipid accumulation, investigators should con-
sider a tool(s) that yields an estimate of triglyceride synthesis and
degradation including the contribution of de novo lipogenesis to the
triglyceride-bound fatty acids [20]. Perhaps the most straightforward
approach for examining lipid deposition is to determine the change in
pool size over time (which equals the synthesis minus the degradation)
while quantifying the rate of lipid synthesis via a tracermethod, one can
solve the equation to estimate the degradation rate [11,12,20].
In our experience, the use of 2H-labeled water offers a number of
advantages as compared to other tracers. In addition to the fact that
labeled water rapidly and evenly distributes throughout body ﬂuids,
it is incorporated into multiple end-products which enables compre-
hensive studies of metabolic ﬂux while requiring a minimum of re-
sources (Fig. 1). Typical tracer protocols require catheterized subjects,
while this is somewhat trivial to setup in a clinical setting the routine
catheterization of animal models is labor intensive. Although there are
no formal rules regarding how long animals should recover following
a surgical manipulation, investigators often allow several days prior to
initiating a tracer study in rodents [6]. To expand on this example, as-
sume that one aims to test a hypothesis in a study requiring ~24 ani-
mals, how long would it take one FTE to conduct the study and collect
Fig. 1. Design considerations for tracer studies. Assuming a single FTE were available, it would require considerably more time to run a study involving ~24 rodents if catheterization
is required; it requires ~2 days to implant catheters, ~4–5 days of post-operative recovery and ~5–6 days to perform tracer infusions vs ~1 day if catheters are not required. Note
the each arrow (→) represents the equivalent of one day.
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catheters in rodents, there may be a recovery period of several days
followed by several more days of effort to perform the tracer infusions
[74,104,119,123,157]. In contrast, using 2H2O it is possible to dramati-
cally reduce the time it takes to move from hypothesis generation to
sample collection. In addition, if it is necessary to scale up the number
of studies, it is possible to run more water-based studies with a mini-
mum of extra effort and in a shorter amount of time as compared to
studies that require catheterization. To circumvent the use of chron-
ically catheterized animal models, Kurland and colleagues have used
mini-osmotic pumps to deliver tracers whereas Bateman and colleagues
have administered a single intraperitoneal bolus of labeled leucine to
study protein synthesis [10,159]. While those approaches are somewhat
easily implemented in rodent models, it is also possible to administer a
more standard intravenous bolus which is suitable for studies in higher
species as well [100,101].
We recognize that lipids may mean glycerides to some and sterols
to others, the focus here is on triglycerides and cholesterol with a con-
sideration of some related topics. We aim to provide examples of how
tracers can and have been used to quantify these ﬂux rates, we hope
that our discussion will help guide and expand the use of tracers in fu-
ture applications [93,113]. Finally, in order to gain a comprehensive un-
derstanding of metabolic regulation it is important to attempt linking
changes in gene expression with alterations in biochemical ﬂux. Unfor-
tunately there can be disproportionate and/or opposing changes be-
tween expression proﬁles and ﬂux [59,154]; although tracer studies
can be used tomake statements regarding biochemical ﬂux they cannot
necessarily explain points of control just as expression proﬁles may be
useful for identifying potential regulatory sites yet they cannot be used
to infer metabolic rates.
2. Why consider lipid ﬂux in white adipose tissue?
A general misconception may be that lipids are stored in adipose
tissue to support periods of prolonged fasting/starvation. In fact, the
regulation of lipid homeostasis by adipose tissue was rigorously exam-
ined nearly 80 years ago [141]. Studies suggested that a large portion of
dietary fat passed through adipose tissue each day (presumably, if a
subject was in energy balance then equivalent amounts of fat would
be stored after a meal and later released during the postabsorptive
period). This point seemed so obvious in 1936 that Schoenheimer and
Rittenberg [141] wrote:
“Instead of comparing the fat tissues to a cellar in which food is stored
for times of emergency, it seems more correct to compare them to an
ice box in which a part of the food is kept during the short intervals
between meals. The fat tissue can therefore be regarded as an energy
buffer. During absorption it takes up in the form of fatty acids excess
of food material not immediately used for the energy requirements.Conversely, during the postabsorptive period it supplies fatty acids
to make up the energy deﬁcit.”
It is of interest to note that this statement was italicized in the
original text, presumably to convey the importance of the observa-
tion. This concept was recently revisited by Frayn and colleagues, it
is safe to say that the conclusions drawn nearly 80 years ago remain
true today despite the marked differences in the methods and models
[45,141]. Other studies have reported temporal changes in the activi-
ty of lipases in response to changes in glucose and insulin vs fasting
suggesting a transient divergence in lipid trafﬁcking away from mus-
cle and towards adipose tissue in humans [42]. A ﬁnal example re-
garding the importance of adipose tissue in maintaining daily lipid
ﬂux is found in the work of Samuel et al. [134], this indirect evidence
serves as an interesting cross-validation. Brieﬂy, they examined how
diet-induced fat accumulation affects hepatic signal transduction relat-
ed to glucose homeostasis.We draw the reader's attention the degree of
fatty liver that was observed (see Figure 1, ref [134]), we estimate that
the total difference in liver triglyceride is ~0.3 g. Although there were
clear differences in the amount of fat in the liver, we believe that that
change was trivial in the context of daily lipid ﬂux. We estimate that
rats on a high-fat would eat ~15 g of fat per day and that the total lipol-
ysis (i.e. glycerol ﬂux) might be ~5 g of triglyceride per day. Based on
these estimates one expects that ~20 g of fat are trafﬁcking through
the circulation per day, of which, the slightest imbalance leads to an im-
mediate and profound impairment in normal insulin signaling. In total,
these observations further support a critical role for adipose tissue in
preventing peripheral lipotoxicity.
The observations noted above raise aﬁnal question regarding adipose
tissue biology, If a substantial amount of circulating lipids are removed
by adipose tissue as part of normal physiological homeostasis are there
conditions in which the ability of adipose tissue to clear fat may be lim-
iting? For example, the removal of triglyceride from blood appears to
be saturable in vivo [51,128]. Considering the need for adipose tissue to
tightly regulate its own lipid ﬂux and its participation in inter-organ
lipid trafﬁcking it should come as no surprise that there are a number
of approaches for quantifying lipid ﬂux in/out of adipose tissue. One
will appreciate that tracermethods per se are helpful in addressing ques-
tions but it is often necessary to couple their use with ancillary tech-
niques, e.g. tissue biopsies and/or surgical manipulations [15,18,130].
3. Quantifying triglyceride kinetics in adipose tissue: direct or
inferred via plasma measurements
3.1. Dietary interventions
In the classic work performed by Hirsch, subjects were fed modi-
ﬁed diets for weeks or months and biopsies of adipose tissue were
obtained at various intervals, triglyceride turnover was estimated by
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tissue remodeled and began to reﬂect the fatty acid composition of
the diet [57]. While intriguing, one obvious consideration with this
approach is that feeding a highly modiﬁed diet may not be practical
and/or may alter the process(es) being studied. It should be noted
that this type of design was also utilized nearly 80 years ago in an el-
egant series of experiments by Kohl [76–78] who fed elaidin to rats
and then measured its accumulation and removal from various sites.
Both Kohl and Hirsh concluded that once deposited in the adipose tis-
sue, fatty acids generally have a long half-life.
Is it possible to accept the seemingly opposite conclusions reached
by Kohl and Hirsh vs Schoenheimer and Rittenberg and Frayn, i.e. lipids
in adipose have a long half-life vs substantial amounts of circulating
lipids pass through adipose tissue daily?We think “yes” if one considers
how the kinetics are described. For example, the early tracer data sup-
port the hypothesis that lipids have a long half-life, the fractional turn-
over of fatty acids in white adipose tissue is quite slow, e.g. a few
percent of the total pool is renewed each day. We believe that any mis-
understandings in the meaning of these apparently different conclu-
sions come from a consideration of the problem, the ﬂux of fatty acids
equals the fractional turnover times the pool size. When we consider
how much white adipose tissue is found in normal healthy subjects
one recognizes that the absolute amount of lipid which is moving
in/out of white adipose tissue in a day approaches that which is typ-
ically consumed. Stated another way, since the pool of triglyceride in
adipose tissue is relatively large in comparison with dietary intake,
stored triglyceride can have a slow turnover (or long half-life) and there-
in lead to the perception that it is somewhat “inert” yet it is playing a cen-
tral role in maintaining daily balance and inter-organ lipid trafﬁcking.
A variant on using dietary interventions involves feeding isotopical-
ly labeled lipids (e.g. triglyceride tracers) [15,18,130] which is advanta-
geous since dietarymodiﬁcations are not needed. Also, this allows acute
studies lasting a few hours or days. Bragdon and Gordon used this ap-
proach to contrast the fate of lipid disposal from triglyceride present
in chylomicrons vs albumin-bound free fatty acids in rats [18]. They
demonstrated that the nature of the circulating fat (i.e. triglyceride vs
free fatty acids) and the nutritional state (i.e. carbohydrate-fed vs fasted)
affected the tissue-speciﬁc distribution. Havel and Goldﬁen extended
those studies in normal and hepatectomized dogs and observed that by
removing the liver there was a minor impact on circulating fatty acids
but a nearly complete inhibition of triglyceride production; they con-
cluded that liver plays a minor role in clearing lipids but a central role
in converting plasma fatty acids into plasma triglycerides [54]. The
work by Havel and Goldﬁen further emphasizes the importance of cou-
pling tracer methods with surgical techniques in order to understand
whole-body integrative physiology.
The use of dietary modiﬁcations and/or the administration of la-
beled lipids suffer from a common assumption. Namely, when using
a labeled triglyceride or fatty acid to study triglyceride turnover it is
important to recognize that positional speciﬁcity of a given lipase may
inﬂuence the result. Since enzymes may prefer certain substrates
[40,47,48,107,108], the chemical structure of the lipid tracer can inﬂu-
ence the apparent kinetics, i.e. the tracer may not follow the tracee
[15,130]. We previously observed an apparent disconnection between
the incorporation of labeled glycerol vs labeled palmitate in epididymal
fat pads in growing mice, that discrepancy was resolved when we de-
termined that, in fact, the fatty acid composition of the fat pads had
changed over time [20]. For example, based on the incorporation of la-
beled glycerol we concluded that ~4.4 μmol triglyceride accumulated
per day in animals fed a standard rodent diet. We then assumed that
~4 to 5 μmol of palmitate should accumulate (i.e. 3 fatty acids per glycer-
ol, of which, palmitate represents ~30 to 40%). However, we measured
the incorporation of labeled palmitate and concluded that slightly less
than ~1 μmol accumulated. Direct measurements of the fatty acid com-
position of adipose tissue then conﬁrmed the tracer data as we found a
substantial remodeling had occurred over the course of our study [20].3.2. Measurements involving arterio-venous balance, microdialysis and
microperfusion
In contrast to methods which rely on tissue biopsies it is possible
to examine organ-speciﬁc uptake and/or production by measuring
arterio-venous balances [41,46,149]. Frayn and co-workers have clever-
ly used this approach to demonstrate a rapid switching of lipase activity
in healthy humans during the fasted to fed transition which appears to
be altered in obese subjects [33,118]. Such input–output analyses have
been used in ex vivo settings aswell; themass-balance concept demon-
strated that triglyceride uptake by isolated-perfused fat pads is satura-
ble [128].
For obvious reasons arterio-venous balance measurements can be
difﬁcult to make, especially when studying multiple organs or when
long term studies are of interest. Although the concepts of the method
are relatively easy to understand, i.e. onemeasures the input and output
across an organ, the assumptionsmay be less obvious. For example, ap-
parent differences in lipid ﬂux between subjects could reﬂect true dif-
ferences and/or artifacts related to tissue heterogeneity or perfusion.
Namely, one assumes that the relative tissue composition is the same
in different subjects and the degree of tissue perfusion is comparable,
i.e. any shunting of blood ﬂow should be equal in all conditions.
Microdialysis and microperfusion techniques allow investiga-
tors a different type of insight regarding tissue-speciﬁc metabolism
[5,136,148,151]. One advantage afforded in such studies is the ability to
implant multiple probes in the same subject and therein simultaneously
study the effect of several perturbations. For example, an investigator can
implant three probes in the abdominal fat of humans, the ﬁrst can be
used to deliver vehicle, the second can deliver an activator of lipolysis
and the third an inhibitor of lipolysis. The use of microperfusion, as com-
pared to microdialysis, is advantageous in that there are fewer limits in
terms of what analytes can be recovered.
All of themethods noted above are useful for probing global aspects
on net lipid ﬂux, however, mass-balance approaches do not address
questions regarding speciﬁc pathways. For example, if one did not ob-
serve a difference in glycerol concentration across an adipose depot it
is probably incorrect to conclude that there is neglible triglyceride turn-
over. The use of a glycerol tracer in this scenario could be highly reveal-
ing, i.e. ﬁnding no difference in concentration but a dilution in the
labeling of glycerolwould lead one to conclude that therewas consider-
able glycerol uptake with a comparable production [32].
3.3. Glycerol and fatty acid ﬂux
All of the methods noted above have a common limitation, namely,
unless every adipose depot is studied one will inevitably make infer-
ences regarding data obtained from one depot to another. The use of
glycerol and/or fatty acid tracers allows one to quantify whole-body
lipid ﬂux [158]. Before engaging in a detailed discussion it is important
to note that whole-body studies are limited since one cannot immedi-
ately ascribe the source of any difference between subjects.
It is generally assumed that (i) the release of free glycerol reﬂects the
rate of triglyceride degradation (i.e. since very little glycerokinase is
found in adipose tissue glycerol cannot be reincorporated) and (ii) the
production of fatty acids can underestimate lipolysis since fatty acids
may be reesteriﬁed directly in adipose tissue [158]. The logic of quantify-
ing glycerol ﬂux (assuming a metabolic steady-state) is straightforward,
one can infuse a glycerol tracer and then measure its dilution in plasma
[16,97,158]. Since the infusion rate is known and the dilution in plasma
is measured one can calculate the production using the equation:




where the units for “infusion rate” (e.g. μmol × kg−1 × min−1) deter-
mine the units for “production rate” [158]. The caveats surrounding
Fig. 2. Overview of lipid ﬂux pathways. Triglyceride synthesis requires a source of
glycerol-3-phosphate and fatty acids, the relative contributions of glycolysis, glycerokinase
and glyceroneogenesis is expected to varywith tissue-type and nutritional/hormonal status;
likewise, fatty acids are derived from variable sources including stored lipids, diet and/or de
novo synthesis (not shown) (Panel A). Plasma cholesterol is derived from three sources and
is disposed of primarily via two pathways, conversion to bile acids and direct elimination
(Panel B). Note that this review does not consider the conversion of cholesterol to other
steroids.
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dogenous glycerol mixes with the infused tracer. In addition, the loss of
tracer from the plasma is via true utilization and not an isotopic ex-
change. For example, perfused rat liver will remove [2H5]glycerol and
release other mass isotopomers of glycerol (i.e. [2H4], [2H3], etc.)
[121]; if this were to occur in vivo, and if unaccounted for, one would
overestimate the true rate of glycerol production, i.e. if some of the de-
crease in the abundance of [2H5]glycerol were to be caused by conver-
sion of the infused tracer to another form of labeled glycerol. There
are other reports which discuss the impact of isotope exchange vs net
production [79,83], although those examples surround carbohydrate
metabolism the concepts have immediate implications here.
The mode under which tracers are infused and samples are col-
lected will impact conclusions regarding glycerol kinetics. Beylot
and colleagues infused postabsorptive and starved rats with [2-13C]
glycerol, in some studies the tracer was infused-sampled using the
arterial-venous mode whereas in other tracer was infused-sampled
via the venous-arterial mode [117]. Regardless of the nutritional state,
the rate of glycerol turnover was approximately double in the arterial-
venous vs the venous-arterial mode. Since most investigators will pre-
sumably choose one mode of tracer infusion-sampling for a given set
of studies the effect on the outcome may be minimized nevertheless
this may be critical when comparing data across different studies [61].
There are several helpful discussions regarding the importance of
infusion-sample modes which review why such striking differences in
ﬂux may be observed [70,109].
A subsequent assumption surrounding measurements of glycerol
ﬂux is that glycerol production reﬂects lipase activity of adipose tis-
sue. However, what lipase are we talking about? Namely, the hydro-
lysis of intracellular triglycerides (e.g. hormone sensitive lipase) will
release glycerol just as the hydrolysis of extracellular triglycerides
(e.g. lipoprotein lipase). Perhaps differentiating the contribution of
intra- and extracellular lipolysis in hyperinsulinemic obese patients
could explain how to best approach apparent alterations in lipolytic
ﬂux observed in obesity [56,57].
We designed studies to quantify the source of glycerol in humans,
[14C]glycerol was used to estimate total glycerol ﬂux and 2H2O was
used to dissect the contribution of intra- vs extra-cellular lipolysis
[60]. The data suggested that ~20% of total glycerol production was
not from lipolysis of adipose tissue triglyceride, presumably there
was substantial hydrolysis of circulating VLDL triglyceride. Those
observations are similar to data obtained by Frayn et al. [46]; using
arterio-venous balancemeasurements they demonstrated that extracel-
lular lipolysis contributes ~20 to 50% to total lipolysis in healthy subjects.
Mittendofer et al. considered this problemusing a different approach and
came to a similar conclusion, i.e. the systemic appearance of fatty acids
does not entirely reﬂect lipolytic ﬂux in adipose tissue [105]. Brieﬂy,
they simultaneously compared the production of multiple fatty acids
against the fatty acid composition of abdominal and gluteal adipose
tissue. Their data suggest that fatty acids are released into the circulation
from a tissue source which contains palmitate and stearate in higher
concentrations and oleate in lower concentrations than certain adipose
tissue depots. Although the site of the unknown lipid depot was not spe-
ciﬁcally determined, the discrepancies between the fatty acid appear-
ance proﬁle and the distribution of fatty acids in adipose tissue
triglyceride were observed during hormone-mediated changes in fatty
acid ﬂux therein suggesting that factorswhich regulate triglyceride turn-
over in adipose tissue do not necessarily regulate this other depot(s).
4. Quantifying triglyceride production: direct incorporationmethods
While the use of the word “triglyceride” is convenient, readers rec-
ognize the heterogeneity of this biochemical class. To simplify matters
we will initially focus our attention on a higher level overview (Fig. 2).
Brieﬂy, triglycerides are made from glycerol-3-phosphate and fatty
acids. Analogous to the fact that fatty acids can be derived frommultiplesources (e.g. diet or de novo synthesis), glycerol-3-phosphate can be
made from glycerol, glucose and “glyceroneogenic” carbon sources
(e.g. pyruvate, lactate, alanine). We hope to contrast the use of fatty acid
and glycerol tracers against the use of labeled water (both 2H and 18O)
as tracers for studying triglyceride production.
4.1. Fatty acid tracers
There are numerous examples in which labeled fatty acids have
been used to estimate triglyceride production [1]. In contrast to the use
of labeled glycerol, one can follow the incorporation of labeled fatty
acids into cholesterol esters, advanced LC–MS methods greatly facilitate
these analyses [100,101,125]. Furthermore, it is possible to simultaneous-
ly administer labeled fatty acids orally and intravenously and therein es-
timate the fate of endogenous vs exogenous lipids [39], depending on the
typeof labeled fatty acid that is administered it is also possible to estimate
lipid oxidation [95].
Wolfe and colleagues recently examined triglyceride synthesis in
muscle, the reported observations have immediate implications on
measures of triglyceride synthesis in liver and adipose tissue [21,161].
Again, the central problem when following the incorporation of a la-
beled precursor into a product concerns the dilution of the tracer [21].
Namely, the labeling of the product reﬂects howmuch tracer is admin-
istered, the turnover of the fatty acid pool or entry of cold fatty acids
along the pathway and the rate of triglyceride production.
Various approaches can be used to administer other labeled pre-
cursors (e.g. 13C-glucose, 13C-acetate or 2H-water), for example, one
can then follow the incorporation of the endogenously synthesized
(isotopically labeled) fatty acids into triglycerides and/or other complex
lipids. It is possible to estimate the contribution of de novo lipogenesis
via the steady-state labeling of palmitate and triglyceride turnover via
the time required to reach a steady-state labeling [2,20,30,38,39,87].
A ﬁnal approach to using “fatty acid tracers” is to measure the dis-
posal of a known amount of Intralipid [133]. Although not necessarily
a tracer-method per se, this approach has merit in some instances
since one can examine questions regarding the effect of different lipid
loads on kinetics, since Intralipid has a somewhat distinct lipid proﬁle
Fig. 3. Isotope exchanges during the incorporation of [2H5]glycerol into triglyceride.
Perdeuterated glycerol is often used in studies of triglyceride synthesis. The bar graph
was adapted from Patterson et al. (see Figure 3, ref [114]) and shows the relative abun-
dance of different mass isotopomers of triglyceride–glycerol ~2 h after administration of
[2H5]glycerol. Although the injected glycerol tracer is predominantly M + 5 (set to 1),
once activated to glycerol-3-phosphate the tracer will rapidly equilibratewith dihydroxy-
acetone phosphate, glyceraldehyde phosphate and 1,3-bisphosphoglycerate (DHAP, GAP
and 1,3-BPG, respectively). Each interconversion exchanges carbon-bound hydrogens
generating lower mass isotopomers. Aldolase (not shown) also participates in these ex-
change reactions, it can generate other mass isotopomers (e.g. M + 1) depending on
the isotopic composition of DHAP and GAP.
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quantify the removal of several lipid species.
4.2. Glycerol tracers
Glycerol is readily incorporated into liver triglyceride and thus circu-
lating triglyceride, the degree towhich adipose tissuewill use glycerol vs
other substrates is questionable [52,84,91]. One can ﬁnd several reports
in which the temporal change in 14C-labeling of triglyceride–glycerol
was measured in humans following the administration of 14C-glycerol,
sophisticated mathematical models were used to inform on the rates of
different reactions [1]. An important consideration regarding these data
centers on the potential for secondary tracers (or isotope recycling).
For example, carbon-labeled glycerol can be converted to carbon-
labeled glucosewhich can thengenerate carbon-labeled lactate, pyruvate,
etc. The conversion of those intermediates to triose-phosphates will lead
to the (re)incorporation of labeled carbon into triglyceride–glycerol. One
potential consequence of this isotopic scrambling is the generation of a
“tail” in the apparent labeling curve of triglyceride–glycerol. Although
recycling is somewhat difﬁcult to detect when using 14C-tracers, the
detectionmethods used in stable isotope studies permit an immediate as-
sessment of 13C recycling. For example, we previously measured the in-
corporation of [U-13C]glycerol (M + 3) into glucose [82,121]. Although
the predominant shift in glucose labeling occurred in the M + 3
isotopomer, we also observed substantial increases in the abundance of
singly and doubly-labeled (M + 1 and M + 2, respectively) glucose. Al-
though our analyses did not aim to deﬁnitively measure rates of tracer
recycling, the data demonstrate the importance of this concept and sug-
gest that a sizeable amount of labeled glycerol will recycle.
Recent investigations have capitalized on the use of [2H5]glycerol.
As noted above, one might expect the appearance of several mass
isotopomers of triglyceride–glycerol following the administration of
[2H5]glycerol. For example, the injected [2H5]glycerol tracer (i.e. M + 5)
is readily phosphorylated and then either immediately incorporated
into triglyceride–glycerol (generating an M + 5 product) or equili-
brated with the triose-phosphate pool which generates various mass
isotopomers of glycerol-3-phosphate depending on the extent of me-
tabolism. Patterson and colleagues clearly demonstrated this in humans
(Fig. 3) [114]. Another “proof” of isotopic scrambling centers on the use
of 2H2O in studies of triglyceride–glycerol ﬂux. For example, the in-
corporation of 2H, following the administration of 2H2O, is possible
via a rapid equilibration between the triose phosphates and glycerol-3-
phosphate (Fig. 3) [20,153].
It is of interest to discuss the recent use of [2H5]glycerol in studies
of triglyceride production by Qi et al. [124]. Brieﬂy, it appears that tri-
glyceride production was estimated by administering a bolus of [2H5]
glycerol and then measuring the abundance of different 2H-labeled
triglycerides. Although Qi et al. [124] concluded that their novel com-
pounds inhibit triglyceride production,we suspect that certain assump-
tions may complicate the interpretation. For example, it appears that
these investigators simply administered [2H5]glycerol and then mea-
sured the concentration of [2H5]triglyceride52:2 in vivo as a marker of
triglyceride production. Why is this concerning? The concentration of
[2H5]triglyceride52:2 is affected by (i) the dose of [2H5]glycerol, (ii) the
initial dilution of the tracer at the extracellular level which is inﬂuenced
by differences in glycerol concentration and/or ﬂux between control
and treated subjects, (iii) isotope exchange at the level of triose
phosphates, (iv) isotope dilution at the level of triose phosphates
and (v) the rate of triglyceride production (Fig. 3). Different levels of di-
lution and/or exchange following the administration of [2H5]glycerol
(i.e. steps ii, iii and iv) make it difﬁcult to deﬁnitively interpret the
data [124,125].
There are a few additional points to consider regarding the conclu-
sion that the incorporation of 2H-glycerol vs 13C-oleate is speciﬁc to a
single enzyme (i.e. DGAT2) [124]. First, as eluded to above, the differ-
ences between the labeled glycerol and fatty acids could simply becaused by overlooked assumptions. Second, it is not clear whether
some form of compensation did not occur, enzymes other than DGAT2
are capable of catalyzing the same reactions. Third, hepatic zonation
of metabolic ﬂux is known to affect the interpretation of tracer data.
For example, different concentration and/or labeling gradients across
the liver (or splanchnic bed)may contribute to the apparent differences
in triglyceride labeling that result following the administration of
2H-glycerol vs 13C-oleate.
Please note that the points being raised here are not meant to re-
ﬂect negatively on the work of Qi et al. [124,125], it could be that the
concerns outlined above have been evaluated by the authors; these
papers are used as examples since experimental details seem to be
absent and fundamental assumptions are not discussed, both would
help readers better understand the conclusions. Discrepancies between
tracer methods and/or other methods are common. For example, the
dogma is (or was) that liver and kidney remove glycerol since these or-
gans contain measureable activities of glycerokinase, a critical enzyme
involved in glycerol metabolism [91]. However, that concept was chal-
lenged by coupling arterio-venous balance measurements of glycerol
concentration and isotopic labeling, the data demonstrated substantial
extra-hepatic and extra-renal glycerol utilization [84]. This raised the
question, How does a tissue use glycerol if glycerokinase is not present?
Howcould a tracermethod yield a different result as compared to directly
measuring enzyme activity? Could bothmethods be correct yet they lead
to different conclusions? Although it is difﬁcult to answer this question
with complete conﬁdence, other pathways of glycerol utilization
have been proposed, e.g. glycerol + NADP→ glyceraldehyde + NADPH
[43,150].
4.3. Application of 2H- or 18O-labeled water
Although readers will likely recognize how 2H2O can be used to
estimate the contribution of de novo lipogenesis, its use in quantify-
ing triglyceride production may be less clear. We will ﬁrst brieﬂy out-
line pivotal discussions in which 2H2O was used to study fatty acid
synthesis and then expand the review to triglyceride ﬂux.
The seminal studies of Schoenheimer and Rittenberg demonstrat-
ed that biosynthetic reactions incorporate protons from body water
Fig. 4. Incorporation of 2H2O into glyceride–glycerol. Mice were fed a high-carbohydrate
or a carbohydrate-free diet for ~2 weeks and then given a single intraperitoneal bolus of
2H2O, the 2H-labeling of water and glyceride–glycerol was determined in plasma samples
(shown as ave, n = 2 per group per time point). Plasmawater labeling reached ~2.2% en-
richment within 20 min and remained stable for the duration of the study (not shown).
The total enrichment of glyceride–glycerol was determined via GC–MS and is expressed
as a ratio relative to the water labeling (y-axis). Each data set was ﬁtted to a single expo-
nential, the asymptotic labeling was expected to reach 3.8 ± 0.4 vs 1.8 ± 0.3 (ave ± se)
in animals fed a high-carbohydrate vs a carbohydrate-free diet, respectively.
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tate are derived from water, NADPH and acetyl-CoA [25]; most but
not all of the hydrogens become labeled [3,37,65,81,155]. We recently
revisited the question of whether the number of hydrogens is constant
when different diets are fed to mice, we concluded that it is reasonable
to make this assumption when studying palmitate and cholesterol syn-
thesis [122]. Lee and colleagues have carefully considered how to exam-
ine questions centered on the elongation of palmitate [3].
Problems of precursor heterogeneity surround studies of fatty
acid synthesis that use carbon-labeled acetate (or a related precur-
sor, e.g. carbon-labeled glucose, ethanol) [22,25,35,36,55]. Namely,
carbon-labeled tracersmay not equally enter all cells which is important
for in vivo studies but may be less important in cell-based studies since
gradients are expected to be less severe [68,103]; Kelleher and col-
leagues have demonstrated a mathematical approach that can account
for labeling gradients provided that one can measure the abundance
of several mass isotopomers [13,14,72,73]. Although 2H2O results in a
more homogenous precursor labeling, isotope effectsmay exist therefore
one assumes that these would be equal across different subjects. Since
2H2O has a relatively long half-life it is somewhat straightforward to
maintain a steady-state labeling for a prolonged time, therein allowing
investigators to obtain integrative measures of ﬂux [3,20,147]. The long
half-life of 2H2O has also been considered a problem when studying
acute interventions, however, it is possible to use a step-wise dosing rou-
tine and therein estimate the ﬂux of some parameters back-to-back
[69,122].
In looking back at the classical study of Jungas, in which 3H2O was
used to quantify fatty acid synthesis, one recognizes that he also mea-
sured the incorporation of 3H into triglyceride–glycerol [65]. 2H2O
was recently proposed as a tracer for estimating rates of triglyceride
production [20,153]. Brieﬂy, 2H can be incorporated into each of the
ﬁve carbon-bound hydrogens of triglyceride–glycerol. Since the incorpo-
ration of 2H does not appear to bemediated by non-speciﬁc exchange re-
actions and saponiﬁcation of isolated triglycerides does not appear to
catalyze the back exchange of 2H, the 2H-labeling of triglyceride–glycerol
should reﬂect the rate of triglyceride synthesis [12,20,29].
Since triglyceride–glycerol can be derived from glucose, glycerol
and glyceroneogenic substrates (e.g. pyruvate) (Fig. 2) [7], our initial
questionwaswhether the labeling of the different hydrogenswas equiv-
alent [20]. If equivalent, it would be possible to simply measure the total
labeling of triglyceride–glycerol and assume a constant number of hy-
drogens (i.e. n) are incorporated, as is the case when studying the de
novo synthesis of palmitate or cholesterol [37,86]. Central to the dis-
cussion here is an appreciation for the stereospeciﬁc action of enzymes
[110,127,131,132]. For example, although glycerol is chemically symmet-
rical glycerokinase selectively phosphorylates carbon 3 (C3) [23,135],
likewise, the labeling of speciﬁc hydrogens is affected by distinct
enzymes.
Our initial studies relied on direct measurements to determine
whether speciﬁc carbon-bound hydrogens were differentially labeled
[20]. We concluded that quantitation of triglyceride turnover over a
short time period (i.e. when one does not model the rate at which tri-
glyceride–glycerol approaches its asymptotic level) required knowledge
of the 2H-labeling on C1triglyceride–glycerol. Later studies by our group relied
on a simpler analytical strategy for measuring the positional labeling of
triglyceride–glycerol [11]. It is important to note the efforts made by
Hellerstein and colleagues, although they calculate rates of triglyceride
ﬂux their approach does not allow one to determine the labeling in spe-
ciﬁc positions [153].
Given the observations reported by Patterson et al. [114], we were
concerned about the potential to underestimate triglyceride production
in plasma if we were to administer 2H2O, sample at a single time point
and assume a constant for n. To test these concerns, mice were either
fed a low-fat or carbohydrate-free diet for ~2 weeks and then given a
single bolus of 2H2O, samples were collected at various time points and
the [2H]labeling of glyceride–glycerol was determined (Fig. 4). Webelieve that these observations underscore the importance of collecting
temporal data, clearly the asymptotic value of total glyceride–glycerol
labeling appears to be inﬂuencedby the diet and therefore itwould like-
ly be incorrect to assume a constant for n. Presumably it would bemore
appropriate to estimate triglyceride production by ﬁtting the time-
dependent change in labeling. Our observation of a lower n in ani-
mals fed a carbohydrate-free diet seems consistent with what might
be expected. If we consider that ~90% of the caloric content of the
carbohydrate-free diet is lipid and that the carbohydrate-free
diet results in substantial triglyceride turnover in white adipose
tissue [12], it is likely that the delivery of free glycerol to the
liver is increased. The extent to which there is direct conversion
of glycerol→ glycerol-3-phosphate→ triglyceride–glycerol might lead
to the observeddifference in the asymptotic labeling of glyceride–glycerol
being lower in animals fed a carbohydrate-free vs a low-fat diet.
We aimed to test the suitability of a novel analytical method for
measuring the 2H-labeling of triglyceride. For example, rapidly evolv-
ing LC–MS protocols make it possible to analyze the labeling of intact
lipids [26,27]. In our experience it seems that one may be able to es-
timate the rate of triglyceride production by administering a single
bolus of 2H2O and then measuring the change in total 2H-labeling of
triglyceride over time (Fig. 5, Panel A). Although the labeling curve
reﬂects a composite of triglyceride–glycerol and triglyceride-fatty
acids, one should be able to estimate the fractional rate of triglyceride
synthesis by ﬁtting the rise to steady-state. While these newer analyt-
ical methods allow one to examine distinct analytes it is not always
possible to obtain good chromatographic separation and/or clean spec-
tra for all analytes [26,27].
Aﬁnal point to consider regarding the use of 2H2O in studies of triglyc-
eride ﬂux centers on quantifying the speciﬁc contributions of glucose,
glycerol and glyceroneogenic carbon sources. It is expected that the
liver will use any/all of these pathways depending on the nutritional/
hormonal status [66,67], however, there is uncertainty regarding the
contribution of the various pathways in white adipose tissue in vivo.
Presumably, understanding the source(s) of triglyceride–glycerol is
important when trying to guide the design of novel therapeutics
that are aimed at mediating disease-associated alterations. Although
the seminal studies of Hanson and colleagues demonstrated a size-
able glyceroneogenic contribution using an ex vivo model, the con-
tents of the media strongly inﬂuenced the contribution of the
different pathways [7]. We previously reviewed the merits of the dif-
ferent in vivo data regarding the sources of glycerol-3-phosphate
[12], it appears that adipose tissue has a marked ﬂexibility when
generating triglyceride–glycerol (consistent with the original report
[7]).
Fig. 5. Incorporation of 2H- or 18O-labeled water into speciﬁc triglycerides. Mice were fed a standard diet and then given a single intraperitoneal bolus of either 2H- or 18O-labeled
water. The labeling of plasma water and speciﬁc triglycerides was determined (data shown as ave ± se, n = 3 per group per time point). The labeling of plasma water was
maintained at ~2.5% for the duration of the study and there was substantial incorporation of 2H or 18O from water into the respective triglycerides. Note that in the case where
2H-labeled water was administered, plasma was saponiﬁed and the 2H-labeling of total palmitate was also measured, the sizeable difference between the labeling of palmitate
and the intact triglycerides suggests that the majority of the increase in triglyceride labeling reﬂects the incorporation of 2H-glycerol. Regardless of the water tracer, the product
labeling reaches several times that of the precursor labeling; this is expected since multiple copies of the precursor are incorporated. Note that triglyceride labeling was determined
using LC-Q-TOF analyses on the intact lipid [27].
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in studies of lipid synthesis [80,106,137,138]. In short, since the hydroly-
sis of complex lipids (e.g. triglyceride and phospholipids) in the presence
of 18O-water will lead to the generation of 18O-labeled fatty acids it
should be possible to estimate lipid synthesis by measuring the
(re)incorporation of those fatty acids into various end-products. Al-
though the previous work relied on rather cumbersome methods for
isolating lipids, and caution had to be exercised in regard to sample
preparation prior to GC–MS analyses, the data were of value [137].
We were intrigued by the potential of using 18O-water in studies of
lipid ﬂux. Brieﬂy, we recently revisited the use of 18O-water for studies
of protein ﬂux and thought that the ability to couple measurements of
lipid ﬂux would be of interest in certain scenarios [162]. Rodents were
given a single bolus of 18O-water and samples were collected at various
time points, lipids were extracted from plasma and subjected to LC–MS
analyses, the temporal incorporation of 18O-water was determined in
select analytes (Fig. 5, Panel B). We found that the asymptotic labeling
of triglyceride52:2 and triglyceride52:3 was several times greater than
that of body water which is consistent with the notion of an ampliﬁca-
tion between the precursor:product labeling ratio of which the ﬁnal
value reﬂects the number of labeled sites [22]. Despite the marked dif-
ferences in the pathways which incorporate 2H vs 18O from body
water, we observed comparable fractional synthetic rates of the speciﬁc
triglycerides, i.e. ~2.28 vs ~2.10 pools per hour, respectively (Fig. 5).
Our pilot studies were followed by a study in which we adminis-
tered 18O-water to mice under various conditions, i.e. control, follow-
ing intravenous injection of Intralipid or the administration of an
inhibitor of microsomal transfer protein [162]. Samples were collected
at ~90 min post-tracer administration and relative rates of lipid and
apoB ﬂux were estimated. It appears that at lower rates of triglyceride
ﬂux there is a fairly direct relationship with apoB ﬂux, this coupling
seems to be lost as the rate of triglyceride ﬂux increases (Fig. 6). Al-
though it is beyond the scope of this review to comment on the inter-
pretation of these data, our observation is consistent with an earlier
study in humans which relied on the use of separate tracers [102]; the
ability to use labeled water allows for a simpler study protocol which
may be uniquely suited for animal models (Fig. 1).5. Ancillary measures when studying lipid kinetics: estimating
body composition and total energy expenditure
Studies aimed at understanding lipid ﬂux may consider estimates
of body composition and/or energy expenditure. We recognize that
various methods can be used to quantify these endpoints and we donot consider the merits of one vs another, our point here is to explain
how isotopically labeled water can be used to make those measure-
ments [4,158].
5.1. Body composition
The principle of using isotopically labeledwater to estimate fatmass
is relatively straightforward. Brieﬂy, a known quantity of either 2H- or
18O-labeled water is administered as a bolus injection. After allowing
for isotope equilibration, a blood sample is collected and the 2H- or
18O-enrichment of bodywater ismeasured, total bodywater is calculat-
ed from the dilution of the tracer. Once total body water is determined,
fat mass can be estimated by assuming that (i) the body is composed of
two basic compartments (i.e. fat-free mass and fat mass) and (ii) there
is a constant relationship between total body water and fat-free dry
mass [98]. Obviously, water-based estimates of body composition do
not permit the assessment of tissue-speciﬁc fat accumulation, imaging
methods and/or direct tissue biopsieswould beneeded to address ques-
tions regarding the localization of fat.
5.2. Total energy expenditure
Total energy expenditure (i.e. basal metabolic rate, thermic effect
of food and physical activity) can be determined by administering a
bolus of “doubly-labeled” water [89,90]. The difference between the
elimination of 18O and 2H from body water equals the fractional rate
of CO2 production, a series of calculations are then performed to esti-
mate energy expenditure [158], the “doubly-labeled”watermethod as-
sumes that 2H is primarily lost as water and that 18O is primarily lost as
water and CO2.
Lifson and McClintock's pioneering work demonstrated strong
agreement between measurements of CO2 production made using
“doubly-labeled”water and indirect calorimetry [89,90], various groups
have since expanded the use of “doubly-labeled” [50,62,139,140]. It is
important to note thatmeasurements of tracer dilution do not immedi-
ately yield an estimate of total energy expenditure. The measurements
allowone to calculate the fractional rates of 2H and 18O turnover in body
water, a number of equations are then used to calculate the rate of CO2
production and energy expenditure. It may be difﬁcult to completely
verify the application of different eqs. in every experimental setting so
some caution should be exercised when interpreting the data [158].
We adapted the “doubly-labeled” water method in order to simulta-
neously estimate CO2 production and lipid and protein ﬂux [11]. The
aim of those experiments had been to couple concepts of mass-balance
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changes in pathway ﬂux that affect adipose vs muscle mass.
6. Cholesterol ﬂux and related processes
The synthesis of cholesterol and related products (e.g. cholesterol
esters and bile acids) has received considerable attention. Rates of de
novo cholesterol synthesis have been estimated using either carbon-
labeled acetate or “heavy”water, however, concerns have been expressed
regarding the use of carbon-labeled substrates [25,36].We aim to provide
a simple example of how 2H-labeledwater can be used to somewhat eas-
ily study the coordinated regulation of pathways surrounding cholesterol
homeostasis. Again, the central point to be made here concerns the logic
of the methods and not necessarily the biology.
Total cholesterol ﬂux can be estimated by administering a single bolus
of labeled cholesterol and then measuring its dilution over time, Ostlund
andMatthews demonstrated that stable isotope tracers arewell suited for
this purpose [111,112]. The ability to differentiate the source(s) of choles-
terol requires additional tracers. For example, cholesterol absorption can
be studied using dual tracer methods whereas 2H-labeled water can be
used to estimate de novo synthesis [17,38,63,64,152,163]. A major path-
way for affecting cholesterol elimination is its conversion to bile acids;
Stellaard and colleagues have rigorously examinedhow to approach stud-
ies of bile acid kinetics [8,9,143–146]. Brieﬂy, althoughbile acids are phys-
ically separated into plasma, bile and intestinal pools, the rate of mixing
between these sites is expected to be much greater than the throughput
(Fig. 7). Consequently, since bile acids behave as a single well-mixed
pool their kinetics can be studied by administering a bile acid tracer(s)
and then determining the initial labeling and the rate of dilution, i.e. the
pool size and fractional turnover, respectively.
Important goals inmanaging dyslipidemia are lowering plasma cho-
lesterol and/or removing cholesterol from peripheral sites (e.g. plaque),
apoA1 kineticsmay be amarker of the latter. Although one can envision
the design of multi-tracer studies to dissect the pathways surrounding
cholesterol homeostasis we provide an example of how 2H2O could be
used to examine several connections (Fig. 7). Brieﬂy, two groups of
mice were fed a standard low-fat, low-cholesterol diet, one group was
treated as controls whereas the other group was given cholestyramine
(~3% by weight mixed with the food). All animals were given a bolus
of 2H2O afterwhich the 2H-labeling of water, cholesterol, cholic acid
and apoA1 were measured at various time intervals. Since a bolus of
waterwas administeredwe expected a slight decrease in the 2H-labeling
of body water, however, since the dilution is virtually identical between
















Fig. 6. Coupling measurements of triglyceride and apoB relative ﬂux rates. Mice were
studied under conditions that were expected to perturb lipoprotein ﬂux, i.e. control
or Intralipid challenge or inhibition of microsomal triglyceride transfer protein (triangles,
squares and circles, respectively). The incorporation of 2H- or 18O-labeled water (open
and closed symbols, respectively) was used to simultaneously estimate the relative ﬂux
of apoB and triglyceride52:2, plasma was collected 90 min after the water tracers were
given. Lipids and apoB were analyzed as described [27,162].cholestyramine on this network. Consistentwithwhat onemight expect,
treatment with cholestyramine induced an increase in cholesterol syn-
thesis, promoted the conversion of newly made cholesterol to cholic
acid and increased cholic acid turnover, a somewhat novel ﬁnding is
the apparent lack of an effect on the fractional rate of apoA1 production
(Fig. 7). Again, as mentioned before, the point of this example is to dem-
onstrate the relative ease with which interrelated metabolic ﬂux rates
can be studied using a single tracer method, a complete mechanistic un-
derstanding of the biochemistry is beyond the scope of this report.7. Measuring isotopic labeling by mass spectrometry: is there a
best approach?
We suspect that it would be easy to either discourage or offend
many readers by choosing a single instrument so we will try to bal-
ance our understanding of the pros and cons regarding the use of var-
ious mass spectrometry systems. Note that although other analytical
platforms can be used to measure the isotopic abundance of different
analytes (e.g. NMR), mass spectrometry-based analyses are perhaps
the most widely used.
In our experience, a standard GC–MS platform is sufﬁcient for run-
ning many of the analyses discussed herein. In addition to the fact
that virtually all GC–MS instruments have small footprints as com-
pared to LC–MS instruments, GC–MS are relatively inexpensive to
purchase, easy to maintain and they generally have robust perfor-
mance records. Numerous methods have been reported for analyzing
small molecules via GC–MS therefore it is possible to easily get started
[16,49,53,115,158]. Some investigators have demonstrated the ability
to adapt small molecule analyses for LC–MS conﬁgurations [99,129],
presumably the utility of LC–MS for lipid analyses centers on methods
for lipidomic-type analyses [27,31]. A central question in terms of
using LC–MS protocols for tracer studies centers on what type of mass
analyzer is better. In our experience, the use of a Q-TOF conﬁguration
has proven to be very powerful [26,27,156]. It seems that one can obtain
highly reproducible measurements of isotope labeling ratios over a
large dynamic range using a non-biased approach. For example,
Q-TOF instruments yield highly reproducible measurements of isotopic
ratios. QQQ instruments offer comparable reproducibility, however,
they usually require pre-determined MRM settings and are therefore
more limited to targeted analyses. We have had mixed success using
“trap”-based instruments, in our experience the analyses yield reliable
information regarding exact mass data but the measurements are typi-
cally limited by a lack of precision and/or accuracy when quantifying
isotopic ratios, this was most obvious when trying to measure isotope
ratios over a wide dynamic range. Recent efforts by our colleagues
have demonstrated a novel approach that should now enable routine
and reliable measurements of isotopic labeling using “trap”-based
mass spectrometers. Brieﬂy, Kasumov and colleagues proposed to ac-
quire data at various resolution settings from which they can construct
a calibration curve to account for any systematic bias in the apparent
isotopic labeling [58]. A ﬁnal point to consider here in terms of coupling
tracer methods with mass spectrometry-based analyses centers on the
emerging use of imaging mass spectrometry to study spatial and tem-
poral ﬂux [75,85].
Our discussion to this point has avoided the topic of how to obtain
lipids for any analyses [31]. In general, unless some level of puriﬁcation is
used one must interpret the data with caution. In our experience, white
adipose tissue contains an overwhelming amount of triglyceride as com-
pared to other glyceride species so that it may be possible to simply as-
sume that any glycerol released after saponiﬁcation is from triglyceride
[20].When studyingplasma-derived lipids, investigators typically use ul-
tracentrifugation to separate lipoprotein fractions before subjecting the
samples for further preparation and mass spectrometry-based analyses
[88,114]. We recently capitalized on the use of a gel-based separation
technique which seems reasonable for studies of lipid ﬂux [101].
Fig. 7. Simultaneous assessment of multiple indicators of cholesterol homeostasis. Mice were fed a standard low-cholesterol diet ± cholestyramine for 5 days and then given a single
intraperitoneal bolus of 2H2O. The 2H-labeling of water, total cholesterol, cholic acid and apoA1 were determined using plasma samples were collected over 48 h (data are shown as
ave ± se, n = 3 per time point per group). Cholestyramine-feeding did not inﬂuence the 2H-labeling of body water but there was a sizeable increase in the contribution of newly
made cholesterol and conversion to cholic acid, in contrast, therewas no apparent effect on the fractional rate of apoA1 synthesis. The 2H-labeling ofwater and cholesterolwas determined
by GC–MS [59] whereas LC–MS was used to determine the 2H-labeling of cholic acid and apoA1 [162].
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Central to metabolic ﬂux studies is an alignment between the
physiological and the mathematical models. We previously reviewed
several concepts regarding compartmentation of triglycerides in adi-
pose tissue, presumably that discussion has implications in regard to
lipid ﬂux in other locations [20]. Our efforts towards studying lipid ac-
cretion relied on a straightforward logic, by measuring the change in
the pool size over time and the rate of synthesis via 2H2O we could
calculate the rate of degradation [11,12,20]. Obviously, in a metabolic
steady-state the production is equal to the degradation. Berman,
Grundy and Howard published a highly useful collection of reports re-
garding early efforts aimed at modeling plasma lipoprotein kinetics
[1]. Other valuable resources, in regard to general concepts, are the pa-
pers by Foster et al. [44] and Ramakrishnan [126]. One important area
that has perhaps seen little attention surrounds reproducibility and/or
propagation of error [11,122,160]; Magkos, Patterson and Mittendorfer
carefully considered thismatter using a range of tracers surrounding lipo-
protein kinetics [94] whereas Matthews et al. [96] rigorously examined
this for studies of leucine ﬂux.
9. Summary
It should be clear that there are a number of methods for studying
lipid kinetics. Obviously, the questions will drive the utilization of the
method(s) and/or inﬂuence the development of new tools. We hope
to have outlined several of the approaches that can be considered
when examining the biochemical basis of lipid ﬂux, presumably the
methods discussed herein can be used to address questions surrounding
the pathogenesis and management of obesity, (diabetic) dyslipidemia,
cardiovascular disease and/or lipotrophic disorders.
Although our attention was mainly focused on questions related
to the dynamics of circulating lipids as well as white adipose tissue
homeostasis, the logic outlined here should allow investigators to
apply the methods in novel areas (e.g. neuroscience or cancer) and/or
shed light on gaps in the ﬁeld. In particular, we believe that attentionto data processingmethodswill be of great value in the future. For exam-
ple, there are numerous examples in the literature which demonstrate
the power of lipidomics [31]. Aswe recently observed, it is possible to ex-
tract information regarding kinetics by coupling stable isotope tracer
methods with LC–MS/MS analyses [26,27]. In our experience, the hard-
ware outperforms the ability of the software to readily extract the label-
ing data.
Lastly, we have found that 2H2O can be used to measure most of the
major reactions that affect triglyceride accumulation (i.e. the rates of
triglyceride synthesis and breakdown, the contribution of de novo lipo-
genesis to the pool of triglyceride-bound fatty acids and the rate of re-
modeling of adipose tissue triglycerides). As well, 2H2O can be used to
study coupled processes (e.g. lipid and protein ﬂux), including a dissec-
tion of carbohydrate ﬂux and DNA synthesis [19,24,28,38,120,147,162].
We expect that advances in instrumentation will continue to improve
the limits of detection and reduce the tracer requirements. This will
have obvious advantages in terms of cost and presumably affect safety
concerns. Aside from occasional/transient nausea and vertigo, we have
not observed any overt signs of toxicity when administering 2H2O. We
generally enrich body water to ~2.5% in rodents, side effects and toxicity
have been demonstrated at higher doses [34,71,116]. Studies performed
in non-human primates typically use doses of 2H2O that are closer to
what is reported in humans (e.g. ~0.5% enrichment), as in human sub-
jects, the required dose of tracer is given in small volumes over an ex-
tended time period without any apparent adverse reactions [56,122].Acknowledgements
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